Life-threatening hyperkalemia following zoledronic acid infusion for Paget's disease: A case report

Journal of Medical Case Reports

Volumn 5, Issue , 2011, Pages

  Panteliou, Eleftheria ^a   Young, Neil ^a   Naysmith, Morag ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADRENALIN; ALKALINE PHOSPHATASE; ATROPINE; BICARBONATE; GLUCONATE CALCIUM; GLUCOSE; INSULIN; LACTIC ACID; POLYSTYRENESULFONATE CALCIUM; POTASSIUM; PROTON; TROPONIN I; UREA; VERAPAMIL; ZOLEDRONIC ACID;

AGED; ANGINA PECTORIS; ARTICLE; BONE PAIN; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DELIRIUM; DISEASE ASSOCIATION; DRUG DOSE INCREASE; ELECTROCARDIOGRAPHY; HEART ARREST; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HUMAN; HYPERKALEMIA; HYPOCALCEMIA; HYPOXIA; INSULIN INFUSION; ISCHEMIC HEART DISEASE; LUNG EDEMA; MALE; PAGET BONE DISEASE; PATIENT MONITORING; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VALVE INSUFFICIENCY; RESUSCITATION; SINGLE DRUG DOSE; TACHYCARDIA; TRICUSPID VALVE REGURGITATION;

EID: 80051577276     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-5-367     Document Type: Article

References (10)

1. Intravenous zoledronic acid: adverse effects on renal function. UK Medicines and Healthcare Products Regulatory Agency, http://www.mhra.gov.uk/ Safetyinformation/DrugSafetyUpdate/CON087704
2. Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. Van Beek E, Cohen L, Leroy I, Ebetino F, Löwik C, Papadopoulos S, Bone 2003 33 805 811 10.1016/j.bone.2003.07.007 14623056 (Pubitemid 37406665)
3. Pharmakokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. Chen T, Berenson J, Vescio R, Swift R, Gilchick A, Goodin S, LoRusso S, Ma P, Ravera C, Deckert F, Schran H, Seaman J, Skerjanec A, J Clin Pharmacol 2002 42 1228 1236 10.1177/009127002762491316 12412821 (Pubitemid 35205058)
4. Cholesterol synthesis is the trigger and isoprenoid dependent interleukin-6 mediated inflammation is the common causative factor and therapeutic target for atherosclerotic vascular disease and age-related disorders including osteoporosis and type 2 diabetes. Omoigui S, Med Hypotheses 2005 65 559 569 10.1016/j.mehy.2005.03.012 15935563 (Pubitemid 40956956)
5. Fever after zoledronic acid administration is due to increase in TNF- and IL-6. Dicuonzo G, Vincenzi B, Santini D, Avvisati G, Rocci L, Battistoni F, Gavasci M, Borzomati D, Coppola R, Tonini G, J Interferon Cytokine Res 2003 23 649 654 10.1089/107999003322558782 14651779 (Pubitemid 37452905)
6. Interleukin 6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE, Am Heart J 2008 155 303 309 10.1016/j.ahj.2007.09.006 18215601
7. Use of alendronate and risk of incident atrial fibrillation in women. Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM, Arch Intern Med 2008 168 826 831 10.1001/archinte.168.8.826 18443257 (Pubitemid 351649266)
8. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Chung Leung P, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, New Engl J Med 2007 356 1809 1822 10.1056/NEJMoa067312 17476007 (Pubitemid 46698462)
9. Is atrial fibrillation an inflammatory disorder? Boos CJ, Anderson RA, Lip GY, Eur Heart J 2006 27 136 149 16278230 (Pubitemid 43069029)
10. Hyperkalemia and ionized hypocalcemia during cardiac arrest and resuscitation: possible culprits for postcountershock arrhythmias? Niemann J, Cairns C, Ann Emerg Med 1999 34 1 7 10.1016/S0196-0644(99)70265-9 10381988 (Pubitemid 29295745)